Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K FABER

Showing results (71-80 of 156) with videos related to

Pageof 16
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1986
The effect of residual beta-cell function on the development of diabetic retinopathyS Madsbad, E Lauritzen, O K Faber, et al.
Acta Medica Scandinavica. Supplementum|January 1, 1979
Pancreatic beta cell secretion during oral and intravenous glucose administrationO K Faber, S Madsbad, H Kehlet, et al.
Gynecologic Oncology|April 1, 1991
Vulvar leiomyomatosis in a patient with esophagogastric leiomyomatosis: review of the syndromeK Faber, M A Jones, D Spratt, et al.
Journal of Biotechnology|July 9, 1998
Purification and characterization of a highly selective epoxide hydrolase from Nocardia sp. EH1W Kroutil, Y Genzel, M Pietzsch, et al.
Acta Endocrinologica|May 1, 1991
The effect of acute hyperglycemia on the plasma C-peptide response to intravenous glucagon or to a mixed meal in insulin-dependent diabetes mellitusH J Gjessing, B Reinholdt, O K Faber, et al.
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie|June 1, 1976
Production of antisera to synthetic benzyloxycarbonyl-C-peptide of human proinsulinO K Faber, J Markussen, V K Naithani, et al.
Diabetes|January 1, 1978
C-peptide metabolism and the liverC Kühl, O K Faber, P Hornnes, et al.
Diabetes Research and Clinical Practice|April 1, 1997
Renal threshold for glucose in non-insulin-dependent diabetic patientsB Ruhnau, O K Faber, K Borch-Johnsen, et al.
Chemistry and Physics of Lipids|April 1, 1990
Strategies for the chemoenzymatic preparation of optically active 1-alkyn-3-olsB I Glänzer, K Königsberger, B Berger, et al.
Diabetologia|January 1, 1982
The transient effect of strict glycaemic control on B cell function in newly diagnosed type 1 (insulin-dependent) diabetic patientsS Madsbad, T Krarup, O K Faber, et al.
Pageof 16

Showing results (71-80 of 156) with videos related to

Sort By:
Pageof 16
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1986
The effect of residual beta-cell function on the development of diabetic retinopathyS Madsbad, E Lauritzen, O K Faber, et al.
Acta Medica Scandinavica. Supplementum|January 1, 1979
Pancreatic beta cell secretion during oral and intravenous glucose administrationO K Faber, S Madsbad, H Kehlet, et al.
Gynecologic Oncology|April 1, 1991
Vulvar leiomyomatosis in a patient with esophagogastric leiomyomatosis: review of the syndromeK Faber, M A Jones, D Spratt, et al.
Journal of Biotechnology|July 9, 1998
Purification and characterization of a highly selective epoxide hydrolase from Nocardia sp. EH1W Kroutil, Y Genzel, M Pietzsch, et al.
Acta Endocrinologica|May 1, 1991
The effect of acute hyperglycemia on the plasma C-peptide response to intravenous glucagon or to a mixed meal in insulin-dependent diabetes mellitusH J Gjessing, B Reinholdt, O K Faber, et al.
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie|June 1, 1976
Production of antisera to synthetic benzyloxycarbonyl-C-peptide of human proinsulinO K Faber, J Markussen, V K Naithani, et al.
Diabetes|January 1, 1978
C-peptide metabolism and the liverC Kühl, O K Faber, P Hornnes, et al.
Diabetes Research and Clinical Practice|April 1, 1997
Renal threshold for glucose in non-insulin-dependent diabetic patientsB Ruhnau, O K Faber, K Borch-Johnsen, et al.
Chemistry and Physics of Lipids|April 1, 1990
Strategies for the chemoenzymatic preparation of optically active 1-alkyn-3-olsB I Glänzer, K Königsberger, B Berger, et al.
Diabetologia|January 1, 1982
The transient effect of strict glycaemic control on B cell function in newly diagnosed type 1 (insulin-dependent) diabetic patientsS Madsbad, T Krarup, O K Faber, et al.
Pageof 16